Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo
Jasper Fuk‐Woo Chan, Yoo Jin Oh, Shuofeng Yuan, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100774-100774
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

COVID-19 drug discovery and treatment options
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 17
Altered host protease determinants for SARS-CoV-2 Omicron
Jasper Fuk‐Woo Chan, Xiner Huang, Bingjie Hu, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 30
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A
Maja Klevanski, Heeyoung Kim, Mike Heilemann, et al.
Antiviral Research (2024) Vol. 225, pp. 105856-105856
Open Access | Times Cited: 7
Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding
Chan-Yong Park, Kibum Kim, Yerin Kim, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16126-16140
Open Access | Times Cited: 7
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination
Lin‐Lei Chen, Lu Lu, Charlotte Yee-Ki Choi, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 9, pp. 1623-1630
Open Access | Times Cited: 49
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, et al.
Life (2023) Vol. 13, Iss. 3, pp. 617-617
Open Access | Times Cited: 15
Potential beneficial effects of functional components of edible plants on COVID-19: Based on their anti-inflammatory and inhibitory effect on SARS-CoV-2
Yijing Pu, Luyao Chen, Xu He, et al.
Food Innovation and Advances (2023) Vol. 2, Iss. 1, pp. 44-59
Open Access | Times Cited: 15
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
Tümay Capraz, Nikolaus F. Kienzl, Elisabeth Laurent, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 33
Plant lectins as potent Anti-coronaviruses, Anti-inflammatory, antinociceptive and antiulcer agents
Emadeldin Hassan E. Konozy, Makarim Elfadil M. Osman, Amina Ibrahim Dirar
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 6, pp. 103301-103301
Open Access | Times Cited: 26
P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation
Ming Liu, Bingtai Lu, Yue Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters
Can Li, Wenchen Song, Jasper Fuk‐Woo Chan, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein
Aakansha Nangarlia, Farah Fazloon Hassen, Gabriela Canziani, et al.
Biochemistry (2023) Vol. 62, Iss. 14, pp. 2115-2127
Open Access | Times Cited: 8
A molecularly engineered lectin destroys EGFR and inhibits the growth of non-small cell lung cancer
Susana M. Chan, Zoe Raglow, Anupama Pal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Microbial lectins as a potential therapeutics for the prevention of certain human diseases
Suna Bektas, Engin Kaptan
Life Sciences (2024) Vol. 346, pp. 122643-122643
Closed Access | Times Cited: 2
Lectibodies as antivirals
Ian Carlosalberto Santisteban Celis, Nobuyuki Matoba
Antiviral Research (2024) Vol. 227, pp. 105901-105901
Closed Access | Times Cited: 2
Mass tag-encoded nanointerfaces for multiplexed mass spectrometric analysis and imaging of biomolecules
Hao Yin, Yanxin Chu, Wei Wang, et al.
Nanoscale (2023) Vol. 15, Iss. 6, pp. 2529-2540
Closed Access | Times Cited: 6
<em>Microcystis viridis</em> NIES-102 Algae Lectin MVL Interacts with the COVID-19 Spike Protein RBDs via Protein-Protein Interaction
Zhengguang Wang, Zhihan Yang, Mami Shishido, et al.
(2024)
Open Access | Times Cited: 1
Microcystis viridis NIES-102 Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) via Protein–Protein Interaction
Zhengguang Wang, Zhihan Yang, Mami Shishido, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6696-6696
Open Access | Times Cited: 1
Molecular Recognition in Confined Space Elucidated with DNA Nanopores and Single-Molecule Force Microscopy
S.-H. Suh, Yongzheng Xing, Alexia Rottensteiner, et al.
Nano Letters (2023) Vol. 23, Iss. 10, pp. 4439-4447
Open Access | Times Cited: 4
Targeting spike glycans to inhibit SARS-CoV2 viral entry
Alex J. Guseman, Linda J. Rennick, Sham Nambulli, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 38
Open Access | Times Cited: 4
Concentration of SARS-CoV-2-Infected Cell Culture Supernatants for Detection of Virus-like Particles by Scanning Electron Microscopy
Marion Le Bideau, Lea Robresco, Jean‐Pierre Baudoin, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2388-2388
Open Access | Times Cited: 4
Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic
Radu Lefter, Prairna Balyan, Ioana-Miruna Balmuș, et al.
Microbiology Research (2024) Vol. 15, Iss. 2, pp. 525-549
Open Access
Glycosylated SARs Cov 2 interaction with plant lectins
Oinam Sangita Devi, Senjam Sunil Singh, Rana Kamei, et al.
Glycoconjugate Journal (2024) Vol. 41, Iss. 3, pp. 185-199
Closed Access
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion
Meng Yu, A. Lin, Faezzah Baharom, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mechanisms of Plasma Ozone and UV-C Sterilization of SARS-CoV-2 Explored through Atomic Force Microscopy
Jinseung Bae, Petr Bednář, Rong Zhu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 37, pp. 49176-49185
Open Access
Page 1 - Next Page

Scroll to top